Clinical Trial Update: Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a triple-drug regimen of docetaxel, carboplatin, and capecitabine before surgery for locally advanced or inflammatory breast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Cancer Research Network | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN